EchoIQ Limited (AU:EIQ) has released an update.
Echo IQ Limited announces an investor webinar to discuss groundbreaking heart failure algorithm study results and their regulatory and commercialization strategies. The webinar, which will feature presentations by key company officers, is scheduled for 11:00am AEST on 12 September 2024, following Echo IQ’s successful showcase at the ESC Congress 2024. Investors can register for the event online and submit questions ahead of the Q&A session.
For further insights into AU:EIQ stock, check out TipRanks’ Stock Analysis page.
